Shardule Shah, PhD, MBA
CEO, Lime Therapeutics

A strong advocate for the NYC biotech community, Shardule is co-founder and CEO of Lime Therapeutics, a company that is developing a novel class of therapies for diseases of dysfunctional lipid biology, including cancer, metabolic disorders, and neurodegenerative disease, and has just announced a collaboration with the Novo Nordisk BioInnovation Hub. Shardule is a Harvard Business School Executive Fellow and was named a Blavatnik Fellow at Harvard University in 2022.

No event found!

Donate One-Time SAPC-CFI


*Required Field